Recap: Neoleukin Therapeutics Q4 Earnings

Neoleukin Therapeutics NLTX reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:05 PM.

Here's what investors need to know about the announcement.

Neoleukin Therapeutics beat estimated earnings by 10.0%, reporting an EPS of $-0.27 versus an estimate of $-0.3.

Revenue was down $0.00 from the same period last year.

Last quarter the company missed on EPS by $0.0 which was followed by a 3.36% increase in the share price the next day.

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.